Importance Mild traumatic brain injury (TBI) is experienced by 55.9 million people globally
each year. The symptoms of mild TBI are diverse and sometimes long-lasting, requiring …

The purpose of this study was to conduct an overview of systematic reviews (SRs) to
appraise the published evidence related to pharmacological interventions after traumatic …

Background Most patients who sustain mild traumatic brain injury (mTBI) have persistent
symptoms at 1 week and 1 month after injury. This systematic review investigated the …

Management of symptoms following traumatic brain injury (TBI) can be complex and
remains a high priority for Department of Defense (DoD) and Department of Veteran Affairs …

Introduction Providing current, reliable and evidence based information for clinicians and
researchers in a synthesised and summarised way can be challenging particularly in the …

Traumatic brain injury (TBI) is a leading cause of death and disability worldwide.
Randomized controlled trials (RCTs) are the cornerstone to evaluate the efficacy of an …

Moderate-to-severe traumatic brain injury (TBI) remains a major global challenge, with rising
incidence, unchanging mortality and lifelong impairments. State-of-the-science reviews are …

Introduction Accounting for 90% of all traumatic brain injuries (TBIs), mild traumatic brain
injury (mTBI) is currently the most frequently seen type of TBI. Although most patients can …

Given the lack of evidence regarding effective pharmacological and non-pharmacological
interventions for pediatric mild traumatic brain injury (mTBI) and the resultant lack of …

More than 75% of patients presenting to level I trauma centers in the United States with
suspicion of TBI sufficient to require a clinical computed tomography scan report injury …